What Are Peptides?

What Are Peptides?

Peptides are short chains of amino acids — typically between 2 and 50 — linked together by peptide bonds. They are the building blocks of proteins but are distinguished by their smaller size and simpler structure. While proteins fold into complex three-dimensional shapes and can contain hundreds or thousands of amino acids, peptides are compact molecules that can act as precise biological signals throughout the body.

Your body naturally produces thousands of peptides that serve as hormones, neurotransmitters, and signaling molecules. Insulin, a 51-amino-acid peptide produced by the pancreas, regulates blood sugar. Oxytocin, a 9-amino-acid peptide, plays roles in social bonding and childbirth. Endorphins, the body's natural painkillers, are peptides that bind to opioid receptors. These natural peptides are essential to virtually every physiological process — from immune defense and wound healing to metabolism, cognition, and reproduction.

Peptide therapeutics have become one of the fastest-growing areas of pharmaceutical research and development. Their high specificity, low toxicity profile (relative to small-molecule drugs), and ability to modulate complex biological pathways make them attractive drug candidates. As of 2026, over 80 peptide drugs have received FDA approval, with hundreds more in clinical trials. The global peptide therapeutics market is projected to exceed $80 billion by 2030, driven largely by the success of GLP-1 receptor agonists like semaglutide and tirzepatide for diabetes and obesity.

How Do Peptides Work?

Receptor Binding & Signaling

Peptides function primarily by binding to specific receptors on cell surfaces, acting as chemical messengers that trigger intracellular signaling cascades. When a peptide binds to its target receptor — much like a key fitting into a lock — it activates downstream molecular pathways that produce a physiological response. For example, GLP-1 receptor agonists bind to GLP-1 receptors on pancreatic beta cells, stimulating insulin secretion. Growth hormone-releasing peptides (GHRPs) bind to ghrelin receptors in the pituitary gland, triggering growth hormone release.

This receptor specificity is what makes peptides so valuable as therapeutics. Unlike broad-acting small molecules that may interact with many receptor types (causing side effects), peptides tend to bind selectively to their target receptors, resulting in more precise biological effects with potentially fewer off-target interactions.

Routes of Administration

The route of administration significantly impacts a peptide's bioavailability and therapeutic efficacy:

Half-Life & Bioavailability

Most natural peptides have very short half-lives — often measured in minutes — because enzymes called peptidases rapidly break them down in the bloodstream. This is why most peptides need to be injected and why pharmaceutical companies invest heavily in modifications to extend peptide half-lives. Semaglutide, for example, has a half-life of approximately 7 days (enabling weekly dosing) thanks to a fatty acid side chain that binds to albumin, shielding it from enzymatic degradation. In contrast, natural GLP-1 has a half-life of only 1-2 minutes.

Types of Therapeutic Peptides

Therapeutic peptides span a wide range of biological functions. On PeptideScholar, we organize them into 9 research categories based on their primary area of study and therapeutic application.

FDA-Approved Peptides

These are the only peptides in our database that have been proven safe and effective through rigorous clinical trials and received formal FDA approval for specific medical indications.

Research Peptides

The majority of peptides discussed in online communities — including BPC-157, TB-500, CJC-1295, Ipamorelin, MOTS-c, and Epithalon — are not FDA approved for any indication. These are commonly referred to as “research peptides” or “investigational compounds.” While some have promising preclinical data, they lack the rigorous human clinical trials required for regulatory approval.

Browse all 25 peptides in our database — each with evidence grades, mechanisms, side effects, and cited research — on our full peptides directory.

Our Evidence Grading System

Every peptide on PeptideScholar is assigned an evidence level from A to D based on the strength and quality of available scientific research. This system helps you quickly distinguish between proven therapeutics and speculative compounds.

Understanding evidence levels is critical for making informed decisions. A peptide with Level C evidence may have exciting preclinical results, but that does not mean it is safe or effective in humans. Animal studies fail to translate to human outcomes the majority of the time.

Side Effects & Safety

Side effects vary significantly between peptides, but there are some general principles that apply across peptide therapy:

Common Side Effects of Peptide Injections

• •Injection site reactions — Redness, swelling, itching, or pain at the injection site. The most common side effect across all injectable peptides.
• •Gastrointestinal effects — Nausea, vomiting, diarrhea, and constipation, particularly common with GLP-1 agonists (semaglutide, tirzepatide).
• •Headache — Reported across many peptide classes, usually transient and dose-dependent.
• •Flushing and dizziness — Common with melanocortin peptides (bremelanotide, Melanotan II).
• •Water retention and joint pain — Associated with growth hormone-releasing peptides (GHRPs) due to GH elevation.

Why Human Data Is Limited

For many popular research peptides, comprehensive human safety data simply does not exist. Conducting clinical trials is expensive (typically $50M-$2B per drug) and time-consuming (10-15 years). Many research peptides are naturally occurring molecules that cannot be easily patented, reducing the financial incentive for pharmaceutical companies to fund large-scale trials. This does not mean they are safe or dangerous — it means we do not know.

FDA Category 2 Ban

In 2024, the FDA placed several popular peptides on the Category 2 list under the Federal Food, Drug, and Cosmetic Act. Substances on this list cannot be used by compounding pharmacies to create products for human use. Notable peptides affected include BPC-157, AOD-9604, and several others. This action was taken because these substances lack adequate safety and efficacy data from human clinical trials, and the FDA determined they pose potential risks when used without proper clinical oversight.

WADA Prohibition

The World Anti-Doping Agency (WADA) prohibits the use of most therapeutic and research peptides in competitive sports under section S0 (non-approved substances) and S2 (peptide hormones, growth factors, and related substances). Athletes should be aware that the use of virtually any non-prescribed peptide could result in a doping violation, regardless of whether it is a controlled substance in their jurisdiction.

Legal Status

The legal landscape for peptides in the United States is complex and varies by peptide type, intended use, and state jurisdiction. Here is a brief overview:

For a comprehensive, state-by-state breakdown of peptide legality, consult our full 50-state legal guide or use the Legal Status Checker tool to look up a specific peptide in your state.

Free Peptide Tools

We built three free tools to help you navigate the peptide landscape. No signup required.